Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma

NCT00933374 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped delayed recruitment

Conditions

Bladder Cancer

Interventions

DRUG: paclitaxel
DRUG: RAD001

Sponsor

Heinrich-Heine University, Duesseldorf